Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001564590-22-013239
Filing Date
2022-04-01
Accepted
2022-04-01 16:30:37
Documents
5
Period of Report
2022-05-27

Document Format Files

Seq Description Document Type Size
1 PRE 14A rlay-pre14a_20220527.htm PRE 14A 1774572
2 GRAPHIC gfsfwujazsfd000004.jpg GRAPHIC 436335
3 GRAPHIC gfsfwujazsfd000002.jpg GRAPHIC 31128
4 GRAPHIC gfsfwujazsfd000003.jpg GRAPHIC 560287
5 GRAPHIC gfsfwujazsfd000001.jpg GRAPHIC 31128
  Complete submission text file 0001564590-22-013239.txt   3234346
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39385 | Film No.: 22798721
SIC: 2836 Biological Products, (No Diagnostic Substances)